Drugs@FDA: FDA-Approved Drugs
Company: HALEON US HOLDINGS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
FLONASE | FLUTICASONE PROPIONATE | 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED;NASAL | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/19/1994 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
01/07/2019 | SUPPL-45 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020121s045lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020121Orig1s045ltr.pdf | |
01/23/2015 | SUPPL-44 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020121s044lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020121Orig1s044ltr.pdf | |
06/17/2014 | SUPPL-43 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/17/2014 | SUPPL-42 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/19/2013 | SUPPL-41 | Manufacturing (CMC) |
Label is not available on this site. |
||
03/26/2004 | SUPPL-30 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20549slr016,20548slr020,20121slr030_flonase_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20549slr016,20548slr020,20121slr030ltr.pdf | |
05/01/2003 | SUPPL-28 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020121s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20121se8-028ltr.pdf | |
05/07/2002 | SUPPL-26 | Manufacturing (CMC)-Packaging |
Label is not available on this site. |
||
03/04/2002 | SUPPL-25 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
02/19/2002 | SUPPL-24 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
05/23/2002 | SUPPL-23 | Efficacy-New Dosing Regimen |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20121s023ltr.pdf |
07/09/2001 | SUPPL-22 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
06/25/2001 | SUPPL-21 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
05/09/2002 | SUPPL-20 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/NDA20121S011.pdf |
08/03/2001 | SUPPL-17 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
06/20/2000 | SUPPL-16 | Manufacturing (CMC) |
Label is not available on this site. |
||
05/17/2000 | SUPPL-15 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
05/09/2002 | SUPPL-13 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/NDA20121S011.pdf |
02/18/2000 | SUPPL-12 | Manufacturing (CMC) |
Label is not available on this site. |
||
05/09/2002 | SUPPL-11 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/NDA20121S011.pdf |
10/01/1998 | SUPPL-10 | Labeling |
Label is not available on this site. |
||
12/11/1998 | SUPPL-9 | Efficacy-New Indication |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20121-S009_FLONASE_prntlbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20121s9ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20121S009_Flonase.cfm | |
09/26/2000 | SUPPL-8 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
02/18/1998 | SUPPL-6 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
10/31/1997 | SUPPL-5 | Efficacy-New Indication |
Review (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20121.pdf |
12/12/1996 | SUPPL-4 | Labeling |
Label is not available on this site. |
||
03/27/1996 | SUPPL-3 | Labeling |
Label is not available on this site. |
||
08/01/1995 | SUPPL-2 | Manufacturing (CMC)-Control |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
01/07/2019 | SUPPL-45 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020121s045lbl.pdf | |
01/23/2015 | SUPPL-44 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020121s044lbl.pdf | |
03/26/2004 | SUPPL-30 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20549slr016,20548slr020,20121slr030_flonase_lbl.pdf | |
05/01/2003 | SUPPL-28 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020121s028lbl.pdf | |
12/11/1998 | SUPPL-9 | Efficacy-New Indication | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20121-S009_FLONASE_prntlbl.pdf |